KRRO
Korro Bio, Inc.
10.20$
-4.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -330.0% | -958.9% | -1,317.0% | -1,576.1% | -1,370.1% | – | – | -2,852.6% | |
| – | – | – | – | – | 55.2% | 48.0% | 82.2% | 110.1% | 74.8% | – | – | 122.3% | |
| – | – | – | – | – | 59.8% | 69.1% | 136.8% | 167.4% | 160.3% | – | – | 391.7% | |
| – | – | – | – | – | 492.2% | -151.7% | 215.6% | -206.7% | -112.4% | – | – | -205.6% | |
| – | – | – | – | – | 63.9% | 4.7% | 9.6% | 16.1% | 6.5% | – | – | 13.3% | |
| – | – | – | – | – | -121.8% | 1,285.5% | -774.0% | 696.9% | 1,154.5% | – | – | -1,159.9% | |
| – | – | – | – | – | 41.0% | 6.7% | 0.3% | 11.7% | 29.4% | – | – | 3,602.1% | |
| – | – | – | – | – | -410.9% | 333.4% | -2,022.7% | -867.6% | -180.4% | – | – | -407.4% | |
| – | – | – | – | – | -394.0% | -963.6% | -1,326.6% | -1,592.1% | -1,376.6% | – | – | -2,865.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.